Enovis Corporation

Enovis Corporation

ENOV·NYSE

$22.57

+2.9%
HealthcareMedical - Devices

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

At a Glance

Live Snapshot
Market Cap$1.30B
EPS-20.8600
P/E Ratio-1.08
Earnings Date08/06/2026

enov

Long Term Debt

Last Annual Value

1.26B

3-Year CAGR

216%

5-Year CAGR

-11%

10-Year CAGR

-1%

Enovis Corporation

Enovis Corporation Competitors Analysis of Long Term Debt

ENOV · NYSE
CompanyLong Term Debt
CAGR 3Y
CAGR 5Y
CAGR 10Y
1.26B
39.4%-9.5%-0.2% 
ITT logo
ITT Inc.
NYSE:ITT
581.50M
367.3%125.8%N/A
14.40M
-40.3%-24.7%-19.2%
182.17M
-4.7%0.8%-10.6%
197.70M
-12.8%6.9%-9.1%
284.41M
-9.4%275.7%N/A
KAI logo
Kadant Inc.
NYSE:KAI
374.50M
51.9%7.3%19.7%
630.40M
8.3%6.5%6.1%
181.66M
27.3%14.9%1.5%
OFLX logo
Omega Flex, Inc.
NASDAQ:OFLX
0.00
N/AN/AN/A
0.00
N/AN/AN/A
Enovis Corporation

Enovis Corporation Fair Value Envelope

ENOV · NYSE

Our analysis suggests that ENOV has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $22.57, this represents a potential HIDDEN relative to our calculated worth for Enovis Corporation.

Intrinsic Value
Current Price: $22.57